UNSPSC 51442301: Indium 111 capromab pendetide

This classification denotes an immunoconjugate with the molecular formula C32H43N7O14.2H+.In, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 03MZ53X1YS. The term Indium 111 capromab pendetide is an International Non-Proprietary Name or INN (See World Health Organization INN reference publication, Volume 13 No. 1, 1999, List 41.).

UNSPSC 51442301 Indium 111 capromab pendetide is a Commodity code nominally designating a radiopharmaceutical agent, yet the recent state and local opportunities tagged under it span radiologic and X-ray equipment procurement, installation, warranty services, and maintenance — work substantially misaligned with the code's medical isotope scope. The opportunities show county governments and special districts soliciting radiologic equipment installations, extended warranties for X-ray machines, maintenance service plans for security and inspection X-ray systems, and copper sulfate supplies. The issuing bodies include Maricopa County, Escambia County Correction, Broward County Aviation Department, and Pasco County, representing a mix of county purchasing offices and specialized county departments. The divergence between the code's nominal pharmaceutical designation and the actual procurement activity suggests this code may be a misclassification artifact in state and local sourcing systems rather than a reliable indicator of indium 111 capromab pendetide demand.

Geographic activity appears concentrated in Florida (Escambia County, Broward County, Pasco County) and Arizona (Maricopa County). Representative recent opportunities include Maricopa County's IFB 362910, posted October 1, 2026, for radiologic equipment and installation at three colleges with a response date of October 22, 2026; Escambia County Correction's sole-source IFB for extended warranty coverage on specified X-ray machines, due August 19, 2026; and Broward County Aviation Department's RFI, posted June 25, 2026, contesting sole-source designation for Rapiscan X-ray inspection system maintenance services, with responses due July 28, 2026. The code shows no recent activity consistent with radiopharmaceutical procurement and does not support reliable business development targeting under its nominal scope.